Aixian Zheng

1.8k total citations
39 papers, 1.6k citations indexed

About

Aixian Zheng is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Aixian Zheng has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Biomedical Engineering, 19 papers in Molecular Biology and 14 papers in Materials Chemistry. Recurrent topics in Aixian Zheng's work include Advanced biosensing and bioanalysis techniques (17 papers), Nanoplatforms for cancer theranostics (14 papers) and Advanced Nanomaterials in Catalysis (8 papers). Aixian Zheng is often cited by papers focused on Advanced biosensing and bioanalysis techniques (17 papers), Nanoplatforms for cancer theranostics (14 papers) and Advanced Nanomaterials in Catalysis (8 papers). Aixian Zheng collaborates with scholars based in China and United States. Aixian Zheng's co-authors include Huanghao Yang, Guonan Chen, Juan Li, Xiaolong Liu, Xiaolong Zhang, Jinru Wang, Jingfeng Liu, Lingjie Wu, Ming Wu and Xiaorong Song and has published in prestigious journals such as Analytical Chemistry, Chemical Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Aixian Zheng

38 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aixian Zheng China 22 945 766 713 233 178 39 1.6k
Meixing Li China 24 1.1k 1.2× 1.2k 1.5× 699 1.0× 180 0.8× 203 1.1× 44 2.1k
Xingyu Luo China 19 580 0.6× 550 0.7× 380 0.5× 170 0.7× 119 0.7× 96 1.4k
Minghui Zan China 23 623 0.7× 924 1.2× 828 1.2× 128 0.5× 513 2.9× 31 1.8k
Zhimei He China 23 918 1.0× 1.4k 1.9× 1.0k 1.4× 139 0.6× 642 3.6× 38 2.4k
Yanjuan Sang China 17 628 0.7× 1.1k 1.5× 1.4k 1.9× 190 0.8× 265 1.5× 23 1.9k
Gabriel Alfranca China 17 518 0.5× 1.0k 1.3× 508 0.7× 84 0.4× 346 1.9× 23 1.5k
Tao Feng China 21 780 0.8× 828 1.1× 895 1.3× 54 0.2× 248 1.4× 56 2.0k
Yinhui Li China 20 1.0k 1.1× 429 0.6× 422 0.6× 134 0.6× 70 0.4× 46 1.5k
Juan Yue China 17 390 0.4× 714 0.9× 668 0.9× 61 0.3× 466 2.6× 30 1.4k
Weidan Na China 24 597 0.6× 501 0.7× 973 1.4× 411 1.8× 91 0.5× 43 1.5k

Countries citing papers authored by Aixian Zheng

Since Specialization
Citations

This map shows the geographic impact of Aixian Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aixian Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aixian Zheng more than expected).

Fields of papers citing papers by Aixian Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aixian Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aixian Zheng. The network helps show where Aixian Zheng may publish in the future.

Co-authorship network of co-authors of Aixian Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Aixian Zheng. A scholar is included among the top collaborators of Aixian Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aixian Zheng. Aixian Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Aixian, Yuling Wu, Jing Lan, et al.. (2025). Highly Efficient Bifunctional Peptides for Tumor Immunotherapy by Simultaneously Activating T Cells and Blocking PD-L1 Immune Checkpoint. ACS Applied Materials & Interfaces. 17(12). 18194–18205.
2.
Ke, Jun, Lei Ding, Rui Lian, et al.. (2025). Activatable chemiluminescence probe based on four-arm PEG-conjugated-pyropheophorbide-a for in vivo autofluorescence-free imaging of peroxynitrite. Science China Chemistry. 68(5). 2125–2137. 3 indexed citations
3.
Sun, Yupeng, Yan Liu, Peiyuan Wang, et al.. (2025). Two-plex in vivo molecular imaging in the second near-infrared window for immunotherapeutic response. Theranostics. 15(10). 4481–4494. 3 indexed citations
4.
Sun, Yupeng, Yan Liu, Rui Li, et al.. (2024). Multifunctional Biomimetic Nanocarriers for Dual‐Targeted Immuno‐Gene Therapy Against Hepatocellular Carcinoma. Advanced Science. 11(34). e2400951–e2400951. 16 indexed citations
5.
Mao, Qianqian, Juan Min, Haiqin Liu, et al.. (2022). Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy. Theranostics. 12(14). 6088–6105. 72 indexed citations
6.
Wang, Yiru, Ming Wu, Peiyuan Wang, et al.. (2022). Biodegradable MnO2-based gene-engineered nanocomposites for chemodynamic therapy and enhanced antitumor immunity. Materials Today Bio. 18. 100531–100531. 8 indexed citations
7.
Zheng, Aixian, Yiru Wang, Youshi Zheng, et al.. (2022). CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade. Molecular Therapy — Nucleic Acids. 27. 998–1009. 20 indexed citations
8.
Wu, Lingjie, Xiaolong Zhang, Aixian Zheng, et al.. (2022). Development and evaluation of a new test kit for determination of immunosuppressants in blood by UHPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 215. 114756–114756. 2 indexed citations
9.
Zheng, Aixian, Haiyan Sun, Yiru Wang, et al.. (2020). A novel long-wavelength off-on fluorescence probe for nitroreductase analysis and hypoxia imaging. Analytica Chimica Acta. 1144. 76–84. 21 indexed citations
11.
12.
Zhang, Da, Aixian Zheng, Juan Li, et al.. (2017). Tumor Microenvironment Activable Self‐Assembled DNA Hybrids for pH and Redox Dual‐Responsive Chemotherapy/PDT Treatment of Hepatocellular Carcinoma. Advanced Science. 4(4). 1600460–1600460. 63 indexed citations
13.
Zhang, Xiaolong, Naishun Liao, Geng Chen, et al.. (2017). A fluorescent turn on nanoprobe for simultaneous visualization of dual-targets involved in cell apoptosis and drug screening in living cells. Nanoscale. 9(30). 10861–10868. 29 indexed citations
14.
Zheng, Aixian, Da Zhang, Ming Wu, et al.. (2016). Multifunctional human serum albumin-modified reduced graphene oxide for targeted photothermal therapy of hepatocellular carcinoma. RSC Advances. 6(14). 11167–11175. 8 indexed citations
16.
Zheng, Aixian, Xiaolong Zhang, Ju Gao, Xiaolong Liu, & Jingfeng Liu. (2016). Peroxidase-like catalytic activity of copper ions and its application for highly sensitive detection of glypican-3. Analytica Chimica Acta. 941. 87–93. 28 indexed citations
17.
Cheng, Zheng, Aixian Zheng, Bo Liu, et al.. (2014). One-pot synthesized DNA-templated Ag/Pt bimetallic nanoclusters as peroxidase mimics for colorimetric detection of thrombin. Chemical Communications. 50(86). 13103–13106. 117 indexed citations
18.
Liu, Jingjing, Xiaorong Song, Yiwei Wang, et al.. (2012). Label-free and fluorescence turn-on aptasensor for protein detection via target-induced silver nanoclusters formation. Analytica Chimica Acta. 749. 70–74. 59 indexed citations
19.
Zheng, Aixian, Jinru Wang, Juan Li, et al.. (2012). Enzyme-free fluorescence aptasensor for amplification detection of human thrombin via target-catalyzed hairpin assembly. Biosensors and Bioelectronics. 36(1). 217–221. 52 indexed citations
20.
Zheng, Aixian, Jinru Wang, Juan Li, et al.. (2011). Nicking enzyme based homogeneous aptasensors for amplification detection of protein. Chemical Communications. 48(3). 374–376. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026